Prostate Cancer / 2011 / Article / Tab 3

Research Article

Proliferative Tumor Doubling Times of Prostatic Carcinoma

Table 3

Proliferative tumor doubling times of prostatic carcinoma.

SpecimenTumorTumor volume, ccBlock with tumorGleason pattern*BrdU % by flow cytometry , daysGrowth rate**

PBr4T12.823T1-F 39.1 ± 0.925.7 ± 4.025X
T1-G 34.2 ± 0.541.5 ± 3.915X
T1-H 33.7 ± 0.348.0 ± 4.013X
T20.121T2-C 33.4 ± 0.397.9 ± 7.87X
Muscle2.6 ± 0.0636.2 ± 135.1

PBr6T10.656T1-B 33.2 ± 0.350.7 ± 1.52X
T1-C 33.1 ± 0.351.1 ± 5.72X
Muscle2.3 ± 0.498.6 ± 12.7

PBr18T10.015T1-B 35.7 ± 2.236.6 ± 7.36X
T20.842T2-B 3 & 45.2 ± 1.152.2 ± 7.04X
T2-D 43.8 ± 0.9108.1 ± 14.82X
T2-D 3 & 43.7 ± 0.757.4 ± 8.94X
T30.755T3-D 313.6 ± 1.717.3 ± 2.613X
T3-E 34.9 ± 0.773.5 ± 9.13X
Muscle2.7 ± 0.1221.7 ± 41.8

PBr16T17.642T1-E 32.0 ± 0.160.0 ± 4.82X
T1-G 47.8 ± 0.219.0 ± 1.77X
Muscle1.4 ± 0.2137.0 ± 33.0

*Gleason pattern: Gleason pattern of the excised tumor section for a given block.
**Growth rate: of matched muscle/ of tumor.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.